Literature DB >> 10668463

Neither caspase-3 nor DNA fragmentation factor is required for high molecular weight DNA degradation in apoptosis.

P R Walker1, J Leblanc, C Carson, M Ribecco, M Sikorska.   

Abstract

In this paper, we show that there is a two-step process of DNA fragmentation in apoptosis; DNA is first cleaved to large fragments of 50-300 kb that are subsequently cleaved to smaller oligonucleosomes in some, but not all cells. Significantly, only the first stage is considered essential for cell death since some cells, for example human MCF7 breast carcinoma cells and human NT2 neuronal cells, do not show this behavior but still display normal nuclear morphological apoptotic changes. In cells that usually produce small fragments blocking the second (internucleosomal) stage of DNA fragmentation prevents neither nuclear condensation nor apoptosis. We are beginning to understand why the extent of DNA fragmentation during apoptosis varies enormously and why it appears to be a function of the cell type not the inducer. Presumably, this reflects the content of not only endonuclease activit(ies) but also on the ability of the cells to activate caspases, particularly caspase-3, and other proteases that may be involved in endonuclease activation. Since NT2 cells activate caspase-3, but do not correctly process DFF45, other factors must also impinge on the inevitability of that process.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668463     DOI: 10.1111/j.1749-6632.1999.tb07921.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  PKCdelta alternatively spliced isoforms modulate cellular apoptosis in retinoic acid-induced differentiation of human NT2 cells and mouse embryonic stem cells.

Authors:  Niketa A Patel; Shijie S Song; Denise R Cooper
Journal:  Gene Expr       Date:  2006

2.  Semi-artificial Fluorescent Molecular Machine for DNA Damage Detection.

Authors:  Vladimir V Didenko; Candace L Minchew; Stewart Shuman; David S Baskin
Journal:  Nano Lett       Date:  2004-12       Impact factor: 11.189

3.  In situ ligation simplified: using PCR fragments for detection of double-strand DNA breaks in tissue sections.

Authors:  Vladimir V Didenko
Journal:  Methods Mol Biol       Date:  2011

4.  Apoptotic DNA degradation into oligonucleosomal fragments, but not apoptotic nuclear morphology, relies on a cytosolic pool of DFF40/CAD endonuclease.

Authors:  Victoria Iglesias-Guimarais; Estel Gil-Guiñon; Gisela Gabernet; Mercè García-Belinchón; María Sánchez-Osuna; Elisenda Casanelles; Joan X Comella; Victor J Yuste
Journal:  J Biol Chem       Date:  2012-01-17       Impact factor: 5.157

5.  Methotrexate induced apoptotic and necrotic chromatin changes in rat myeloid leukemia cells.

Authors:  Gyorgy Trencsenyi; Fruzsina Bako; Gabor Nagy; Pal Kertai; Gaspar Banfalvi
Journal:  Inflamm Res       Date:  2015-02-12       Impact factor: 4.575

6.  Distribution, histochemical and enzyme histochemical characterization of mast cells in dogs.

Authors:  Deni Noviana; Koichi Mamba; Susumu Makimura; Yoichiro Horii
Journal:  J Mol Histol       Date:  2004-02       Impact factor: 2.611

Review 7.  Cellular and molecular themes in apoptosis.

Authors:  Faris Q Alenzi; Anthony N Warrens
Journal:  Wien Klin Wochenschr       Date:  2003-09-15       Impact factor: 1.704

8.  Alteration of TEAD1 expression levels confers apoptotic resistance through the transcriptional up-regulation of Livin.

Authors:  André Landin Malt; Julie Cagliero; Kevin Legent; Joël Silber; Alain Zider; Domenico Flagiello
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

9.  Fluorescent probes detecting the phagocytic phase of apoptosis: enzyme-substrate complexes of topoisomerase and DNA.

Authors:  Candace L Minchew; Vladimir V Didenko
Journal:  Molecules       Date:  2011-06-03       Impact factor: 4.411

10.  Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy.

Authors:  Myriam González; María Ovejero-Sánchez; Alba Vicente-Blázquez; Raquel Álvarez; Ana B Herrero; Manuel Medarde; Rogelio González-Sarmiento; Rafael Peláez
Journal:  Int J Mol Sci       Date:  2021-02-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.